Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)
This study has been completed.
Study NCT01322347 Information provided by Rockwell Medical Technologies, Inc.
First Received on March 22, 2011. Last Updated on April 3, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Kidney Failure, Chronic
More general conditions related to this trial
Renal Insufficiency, Chronic
Interventions listed in this trial
Soluble Ferric Pyrophosphate (SFP)
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Physiological Effects of Drugs
Sponsors listed in this trial
Rockwell Medical Technologies, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers